nodes	percent_of_prediction	percent_of_DWPC	metapath
Nabilone—Dronabinol—ABCB1—colon cancer	0.0281	1	CrCbGaD
Nabilone—Sleep disorder—Capecitabine—colon cancer	0.00491	0.00506	CcSEcCtD
Nabilone—Stomatitis—Vincristine—colon cancer	0.0049	0.00504	CcSEcCtD
Nabilone—Photosensitivity—Capecitabine—colon cancer	0.00484	0.00498	CcSEcCtD
Nabilone—Photosensitivity reaction—Fluorouracil—colon cancer	0.0048	0.00494	CcSEcCtD
Nabilone—Stomatitis—Irinotecan—colon cancer	0.00477	0.00491	CcSEcCtD
Nabilone—Stomatitis—Fluorouracil—colon cancer	0.00457	0.0047	CcSEcCtD
Nabilone—Hot flush—Capecitabine—colon cancer	0.00455	0.00468	CcSEcCtD
Nabilone—Increased appetite—Capecitabine—colon cancer	0.00453	0.00466	CcSEcCtD
Nabilone—Menopausal symptoms—Capecitabine—colon cancer	0.00451	0.00464	CcSEcCtD
Nabilone—Hallucination—Vincristine—colon cancer	0.00449	0.00462	CcSEcCtD
Nabilone—Hypoaesthesia—Vincristine—colon cancer	0.00449	0.00462	CcSEcCtD
Nabilone—Thirst—Capecitabine—colon cancer	0.00447	0.0046	CcSEcCtD
Nabilone—Epistaxis—Fluorouracil—colon cancer	0.00442	0.00455	CcSEcCtD
Nabilone—Cerebrovascular accident—Capecitabine—colon cancer	0.00434	0.00447	CcSEcCtD
Nabilone—Visual impairment—Irinotecan—colon cancer	0.00424	0.00436	CcSEcCtD
Nabilone—Depressed level of consciousness—Methotrexate—colon cancer	0.00421	0.00433	CcSEcCtD
Nabilone—Hypoaesthesia—Fluorouracil—colon cancer	0.00419	0.00431	CcSEcCtD
Nabilone—Pharyngitis—Fluorouracil—colon cancer	0.00418	0.0043	CcSEcCtD
Nabilone—Face oedema—Capecitabine—colon cancer	0.00411	0.00423	CcSEcCtD
Nabilone—Flushing—Irinotecan—colon cancer	0.00408	0.0042	CcSEcCtD
Nabilone—Irritability—Capecitabine—colon cancer	0.00406	0.00418	CcSEcCtD
Nabilone—Urinary retention—Capecitabine—colon cancer	0.00404	0.00416	CcSEcCtD
Nabilone—Mood swings—Capecitabine—colon cancer	0.00403	0.00415	CcSEcCtD
Nabilone—Ataxia—Capecitabine—colon cancer	0.004	0.00412	CcSEcCtD
Nabilone—Coma—Methotrexate—colon cancer	0.00399	0.0041	CcSEcCtD
Nabilone—Chills—Irinotecan—colon cancer	0.00395	0.00406	CcSEcCtD
Nabilone—Arrhythmia—Irinotecan—colon cancer	0.00393	0.00404	CcSEcCtD
Nabilone—Orthostatic hypotension—Capecitabine—colon cancer	0.00388	0.004	CcSEcCtD
Nabilone—Back pain—Vincristine—colon cancer	0.0038	0.00391	CcSEcCtD
Nabilone—Gastritis—Capecitabine—colon cancer	0.00376	0.00387	CcSEcCtD
Nabilone—Arrhythmia—Fluorouracil—colon cancer	0.00376	0.00387	CcSEcCtD
Nabilone—Back pain—Irinotecan—colon cancer	0.0037	0.00381	CcSEcCtD
Nabilone—Anaemia—Vincristine—colon cancer	0.00363	0.00374	CcSEcCtD
Nabilone—Agitation—Vincristine—colon cancer	0.00361	0.00372	CcSEcCtD
Nabilone—Photosensitivity—Methotrexate—colon cancer	0.00361	0.00371	CcSEcCtD
Nabilone—Sweating increased—Capecitabine—colon cancer	0.00358	0.00368	CcSEcCtD
Nabilone—Ill-defined disorder—Irinotecan—colon cancer	0.00355	0.00365	CcSEcCtD
Nabilone—Anaemia—Irinotecan—colon cancer	0.00354	0.00364	CcSEcCtD
Nabilone—Vertigo—Vincristine—colon cancer	0.00353	0.00363	CcSEcCtD
Nabilone—Leukopenia—Vincristine—colon cancer	0.00352	0.00362	CcSEcCtD
Nabilone—Vision blurred—Fluorouracil—colon cancer	0.00345	0.00355	CcSEcCtD
Nabilone—Malaise—Irinotecan—colon cancer	0.00345	0.00355	CcSEcCtD
Nabilone—Vertigo—Irinotecan—colon cancer	0.00344	0.00354	CcSEcCtD
Nabilone—Syncope—Irinotecan—colon cancer	0.00343	0.00353	CcSEcCtD
Nabilone—Leukopenia—Irinotecan—colon cancer	0.00343	0.00353	CcSEcCtD
Nabilone—Convulsion—Vincristine—colon cancer	0.00341	0.0035	CcSEcCtD
Nabilone—Hypertension—Vincristine—colon cancer	0.00339	0.00349	CcSEcCtD
Nabilone—Anaemia—Fluorouracil—colon cancer	0.00339	0.00349	CcSEcCtD
Nabilone—Loss of consciousness—Irinotecan—colon cancer	0.00336	0.00346	CcSEcCtD
Nabilone—Photosensitivity reaction—Capecitabine—colon cancer	0.00336	0.00345	CcSEcCtD
Nabilone—Myalgia—Vincristine—colon cancer	0.00335	0.00344	CcSEcCtD
Nabilone—Visual disturbance—Methotrexate—colon cancer	0.00334	0.00344	CcSEcCtD
Nabilone—Cough—Irinotecan—colon cancer	0.00334	0.00344	CcSEcCtD
Nabilone—Hypertension—Irinotecan—colon cancer	0.0033	0.0034	CcSEcCtD
Nabilone—Leukopenia—Fluorouracil—colon cancer	0.00328	0.00338	CcSEcCtD
Nabilone—Depression—Capecitabine—colon cancer	0.00327	0.00336	CcSEcCtD
Nabilone—Cerebrovascular accident—Methotrexate—colon cancer	0.00323	0.00332	CcSEcCtD
Nabilone—Discomfort—Irinotecan—colon cancer	0.00322	0.00331	CcSEcCtD
Nabilone—Stomatitis—Capecitabine—colon cancer	0.0032	0.00329	CcSEcCtD
Nabilone—Infection—Vincristine—colon cancer	0.00319	0.00328	CcSEcCtD
Nabilone—Convulsion—Fluorouracil—colon cancer	0.00318	0.00327	CcSEcCtD
Nabilone—Confusional state—Irinotecan—colon cancer	0.00315	0.00324	CcSEcCtD
Nabilone—Chest pain—Fluorouracil—colon cancer	0.00312	0.00321	CcSEcCtD
Nabilone—Myalgia—Fluorouracil—colon cancer	0.00312	0.00321	CcSEcCtD
Nabilone—Infection—Irinotecan—colon cancer	0.0031	0.00319	CcSEcCtD
Nabilone—Hyperhidrosis—Vincristine—colon cancer	0.0031	0.00319	CcSEcCtD
Nabilone—Epistaxis—Capecitabine—colon cancer	0.00309	0.00318	CcSEcCtD
Nabilone—Discomfort—Fluorouracil—colon cancer	0.00308	0.00317	CcSEcCtD
Nabilone—Shock—Irinotecan—colon cancer	0.00307	0.00316	CcSEcCtD
Nabilone—Anorexia—Vincristine—colon cancer	0.00306	0.00315	CcSEcCtD
Nabilone—Irritability—Methotrexate—colon cancer	0.00302	0.00311	CcSEcCtD
Nabilone—Hyperhidrosis—Irinotecan—colon cancer	0.00302	0.00311	CcSEcCtD
Nabilone—Confusional state—Fluorouracil—colon cancer	0.00302	0.0031	CcSEcCtD
Nabilone—Mood swings—Methotrexate—colon cancer	0.003	0.00309	CcSEcCtD
Nabilone—Hypotension—Vincristine—colon cancer	0.003	0.00308	CcSEcCtD
Nabilone—Anorexia—Irinotecan—colon cancer	0.00298	0.00306	CcSEcCtD
Nabilone—Ataxia—Methotrexate—colon cancer	0.00298	0.00306	CcSEcCtD
Nabilone—Infection—Fluorouracil—colon cancer	0.00297	0.00306	CcSEcCtD
Nabilone—Hypoaesthesia—Capecitabine—colon cancer	0.00293	0.00301	CcSEcCtD
Nabilone—Musculoskeletal discomfort—Vincristine—colon cancer	0.00292	0.00301	CcSEcCtD
Nabilone—Pharyngitis—Capecitabine—colon cancer	0.00292	0.00301	CcSEcCtD
Nabilone—Tachycardia—Fluorouracil—colon cancer	0.00292	0.003	CcSEcCtD
Nabilone—Hypotension—Irinotecan—colon cancer	0.00292	0.003	CcSEcCtD
Nabilone—Insomnia—Vincristine—colon cancer	0.0029	0.00298	CcSEcCtD
Nabilone—Paraesthesia—Vincristine—colon cancer	0.00288	0.00296	CcSEcCtD
Nabilone—Anorexia—Fluorouracil—colon cancer	0.00285	0.00293	CcSEcCtD
Nabilone—Visual impairment—Capecitabine—colon cancer	0.00284	0.00292	CcSEcCtD
Nabilone—Insomnia—Irinotecan—colon cancer	0.00283	0.00291	CcSEcCtD
Nabilone—Paraesthesia—Irinotecan—colon cancer	0.0028	0.00289	CcSEcCtD
Nabilone—Hypotension—Fluorouracil—colon cancer	0.0028	0.00288	CcSEcCtD
Nabilone—Decreased appetite—Vincristine—colon cancer	0.00279	0.00287	CcSEcCtD
Nabilone—Dyspnoea—Irinotecan—colon cancer	0.00278	0.00287	CcSEcCtD
Nabilone—Somnolence—Irinotecan—colon cancer	0.00278	0.00286	CcSEcCtD
Nabilone—Fatigue—Vincristine—colon cancer	0.00277	0.00285	CcSEcCtD
Nabilone—Eye disorder—Capecitabine—colon cancer	0.00275	0.00283	CcSEcCtD
Nabilone—Dyspepsia—Irinotecan—colon cancer	0.00275	0.00283	CcSEcCtD
Nabilone—Tinnitus—Capecitabine—colon cancer	0.00274	0.00282	CcSEcCtD
Nabilone—Pain—Vincristine—colon cancer	0.00274	0.00282	CcSEcCtD
Nabilone—Constipation—Vincristine—colon cancer	0.00274	0.00282	CcSEcCtD
Nabilone—Flushing—Capecitabine—colon cancer	0.00273	0.00281	CcSEcCtD
Nabilone—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.00273	0.0028	CcSEcCtD
Nabilone—Decreased appetite—Irinotecan—colon cancer	0.00272	0.00279	CcSEcCtD
Nabilone—Insomnia—Fluorouracil—colon cancer	0.00271	0.00278	CcSEcCtD
Nabilone—Fatigue—Irinotecan—colon cancer	0.00269	0.00277	CcSEcCtD
Nabilone—Paraesthesia—Fluorouracil—colon cancer	0.00269	0.00276	CcSEcCtD
Nabilone—Pain—Irinotecan—colon cancer	0.00267	0.00275	CcSEcCtD
Nabilone—Constipation—Irinotecan—colon cancer	0.00267	0.00275	CcSEcCtD
Nabilone—Dyspnoea—Fluorouracil—colon cancer	0.00267	0.00274	CcSEcCtD
Nabilone—Somnolence—Fluorouracil—colon cancer	0.00266	0.00274	CcSEcCtD
Nabilone—Chills—Capecitabine—colon cancer	0.00264	0.00272	CcSEcCtD
Nabilone—Dyspepsia—Fluorouracil—colon cancer	0.00263	0.00271	CcSEcCtD
Nabilone—Arrhythmia—Capecitabine—colon cancer	0.00263	0.0027	CcSEcCtD
Nabilone—Gastrointestinal pain—Vincristine—colon cancer	0.00262	0.0027	CcSEcCtD
Nabilone—Decreased appetite—Fluorouracil—colon cancer	0.0026	0.00268	CcSEcCtD
Nabilone—Feeling abnormal—Irinotecan—colon cancer	0.00257	0.00265	CcSEcCtD
Nabilone—Pain—Fluorouracil—colon cancer	0.00256	0.00263	CcSEcCtD
Nabilone—Gastrointestinal pain—Irinotecan—colon cancer	0.00255	0.00263	CcSEcCtD
Nabilone—Body temperature increased—Vincristine—colon cancer	0.00254	0.00261	CcSEcCtD
Nabilone—Abdominal pain—Vincristine—colon cancer	0.00254	0.00261	CcSEcCtD
Nabilone—Photosensitivity reaction—Methotrexate—colon cancer	0.0025	0.00257	CcSEcCtD
Nabilone—Back pain—Capecitabine—colon cancer	0.00248	0.00255	CcSEcCtD
Nabilone—Abdominal pain—Irinotecan—colon cancer	0.00247	0.00254	CcSEcCtD
Nabilone—Body temperature increased—Irinotecan—colon cancer	0.00247	0.00254	CcSEcCtD
Nabilone—Feeling abnormal—Fluorouracil—colon cancer	0.00247	0.00254	CcSEcCtD
Nabilone—Drowsiness—Methotrexate—colon cancer	0.00244	0.00251	CcSEcCtD
Nabilone—Depression—Methotrexate—colon cancer	0.00243	0.0025	CcSEcCtD
Nabilone—Vision blurred—Capecitabine—colon cancer	0.00241	0.00248	CcSEcCtD
Nabilone—Tremor—Capecitabine—colon cancer	0.0024	0.00247	CcSEcCtD
Nabilone—Stomatitis—Methotrexate—colon cancer	0.00238	0.00245	CcSEcCtD
Nabilone—Ill-defined disorder—Capecitabine—colon cancer	0.00238	0.00245	CcSEcCtD
Nabilone—Anaemia—Capecitabine—colon cancer	0.00237	0.00244	CcSEcCtD
Nabilone—Body temperature increased—Fluorouracil—colon cancer	0.00237	0.00243	CcSEcCtD
Nabilone—Hypersensitivity—Vincristine—colon cancer	0.00236	0.00243	CcSEcCtD
Nabilone—Malaise—Capecitabine—colon cancer	0.00231	0.00238	CcSEcCtD
Nabilone—Epistaxis—Methotrexate—colon cancer	0.0023	0.00237	CcSEcCtD
Nabilone—Vertigo—Capecitabine—colon cancer	0.0023	0.00237	CcSEcCtD
Nabilone—Hypersensitivity—Irinotecan—colon cancer	0.0023	0.00237	CcSEcCtD
Nabilone—Asthenia—Vincristine—colon cancer	0.0023	0.00237	CcSEcCtD
Nabilone—Syncope—Capecitabine—colon cancer	0.0023	0.00236	CcSEcCtD
Nabilone—Leukopenia—Capecitabine—colon cancer	0.00229	0.00236	CcSEcCtD
Nabilone—Palpitations—Capecitabine—colon cancer	0.00226	0.00233	CcSEcCtD
Nabilone—Loss of consciousness—Capecitabine—colon cancer	0.00225	0.00232	CcSEcCtD
Nabilone—Asthenia—Irinotecan—colon cancer	0.00224	0.00231	CcSEcCtD
Nabilone—Cough—Capecitabine—colon cancer	0.00224	0.0023	CcSEcCtD
Nabilone—Hypertension—Capecitabine—colon cancer	0.00221	0.00228	CcSEcCtD
Nabilone—Hypersensitivity—Fluorouracil—colon cancer	0.0022	0.00227	CcSEcCtD
Nabilone—Diarrhoea—Vincristine—colon cancer	0.00219	0.00226	CcSEcCtD
Nabilone—Arthralgia—Capecitabine—colon cancer	0.00218	0.00224	CcSEcCtD
Nabilone—Myalgia—Capecitabine—colon cancer	0.00218	0.00224	CcSEcCtD
Nabilone—Chest pain—Capecitabine—colon cancer	0.00218	0.00224	CcSEcCtD
Nabilone—Pharyngitis—Methotrexate—colon cancer	0.00217	0.00224	CcSEcCtD
Nabilone—Anxiety—Capecitabine—colon cancer	0.00217	0.00224	CcSEcCtD
Nabilone—Discomfort—Capecitabine—colon cancer	0.00215	0.00222	CcSEcCtD
Nabilone—Diarrhoea—Irinotecan—colon cancer	0.00214	0.0022	CcSEcCtD
Nabilone—Dry mouth—Capecitabine—colon cancer	0.00213	0.00219	CcSEcCtD
Nabilone—Dizziness—Vincristine—colon cancer	0.00212	0.00218	CcSEcCtD
Nabilone—Pruritus—Fluorouracil—colon cancer	0.00212	0.00218	CcSEcCtD
Nabilone—Visual impairment—Methotrexate—colon cancer	0.00211	0.00217	CcSEcCtD
Nabilone—Confusional state—Capecitabine—colon cancer	0.00211	0.00217	CcSEcCtD
Nabilone—Infection—Capecitabine—colon cancer	0.00208	0.00214	CcSEcCtD
Nabilone—Dizziness—Irinotecan—colon cancer	0.00207	0.00213	CcSEcCtD
Nabilone—Shock—Capecitabine—colon cancer	0.00206	0.00212	CcSEcCtD
Nabilone—Eye disorder—Methotrexate—colon cancer	0.00205	0.00211	CcSEcCtD
Nabilone—Diarrhoea—Fluorouracil—colon cancer	0.00205	0.00211	CcSEcCtD
Nabilone—Tinnitus—Methotrexate—colon cancer	0.00204	0.0021	CcSEcCtD
Nabilone—Tachycardia—Capecitabine—colon cancer	0.00204	0.0021	CcSEcCtD
Nabilone—Vomiting—Vincristine—colon cancer	0.00204	0.0021	CcSEcCtD
Nabilone—Rash—Vincristine—colon cancer	0.00202	0.00208	CcSEcCtD
Nabilone—Hyperhidrosis—Capecitabine—colon cancer	0.00202	0.00208	CcSEcCtD
Nabilone—Dermatitis—Vincristine—colon cancer	0.00202	0.00208	CcSEcCtD
Nabilone—Headache—Vincristine—colon cancer	0.00201	0.00207	CcSEcCtD
Nabilone—Anorexia—Capecitabine—colon cancer	0.00199	0.00205	CcSEcCtD
Nabilone—Vomiting—Irinotecan—colon cancer	0.00199	0.00204	CcSEcCtD
Nabilone—Dizziness—Fluorouracil—colon cancer	0.00198	0.00204	CcSEcCtD
Nabilone—Rash—Irinotecan—colon cancer	0.00197	0.00203	CcSEcCtD
Nabilone—Dermatitis—Irinotecan—colon cancer	0.00197	0.00202	CcSEcCtD
Nabilone—Chills—Methotrexate—colon cancer	0.00197	0.00202	CcSEcCtD
Nabilone—Headache—Irinotecan—colon cancer	0.00196	0.00201	CcSEcCtD
Nabilone—Hypotension—Capecitabine—colon cancer	0.00195	0.00201	CcSEcCtD
Nabilone—Nausea—Vincristine—colon cancer	0.00191	0.00196	CcSEcCtD
Nabilone—Musculoskeletal discomfort—Capecitabine—colon cancer	0.0019	0.00196	CcSEcCtD
Nabilone—Vomiting—Fluorouracil—colon cancer	0.0019	0.00196	CcSEcCtD
Nabilone—Insomnia—Capecitabine—colon cancer	0.00189	0.00195	CcSEcCtD
Nabilone—Rash—Fluorouracil—colon cancer	0.00189	0.00194	CcSEcCtD
Nabilone—Dermatitis—Fluorouracil—colon cancer	0.00188	0.00194	CcSEcCtD
Nabilone—Paraesthesia—Capecitabine—colon cancer	0.00188	0.00193	CcSEcCtD
Nabilone—Headache—Fluorouracil—colon cancer	0.00187	0.00193	CcSEcCtD
Nabilone—Dyspnoea—Capecitabine—colon cancer	0.00186	0.00192	CcSEcCtD
Nabilone—Nausea—Irinotecan—colon cancer	0.00186	0.00191	CcSEcCtD
Nabilone—Back pain—Methotrexate—colon cancer	0.00184	0.0019	CcSEcCtD
Nabilone—Dyspepsia—Capecitabine—colon cancer	0.00184	0.00189	CcSEcCtD
Nabilone—Decreased appetite—Capecitabine—colon cancer	0.00182	0.00187	CcSEcCtD
Nabilone—Fatigue—Capecitabine—colon cancer	0.0018	0.00185	CcSEcCtD
Nabilone—Vision blurred—Methotrexate—colon cancer	0.0018	0.00185	CcSEcCtD
Nabilone—Pain—Capecitabine—colon cancer	0.00179	0.00184	CcSEcCtD
Nabilone—Constipation—Capecitabine—colon cancer	0.00179	0.00184	CcSEcCtD
Nabilone—Nausea—Fluorouracil—colon cancer	0.00178	0.00183	CcSEcCtD
Nabilone—Ill-defined disorder—Methotrexate—colon cancer	0.00177	0.00182	CcSEcCtD
Nabilone—Anaemia—Methotrexate—colon cancer	0.00176	0.00181	CcSEcCtD
Nabilone—Feeling abnormal—Capecitabine—colon cancer	0.00172	0.00177	CcSEcCtD
Nabilone—Malaise—Methotrexate—colon cancer	0.00172	0.00177	CcSEcCtD
Nabilone—Vertigo—Methotrexate—colon cancer	0.00171	0.00176	CcSEcCtD
Nabilone—Gastrointestinal pain—Capecitabine—colon cancer	0.00171	0.00176	CcSEcCtD
Nabilone—Leukopenia—Methotrexate—colon cancer	0.00171	0.00176	CcSEcCtD
Nabilone—Cough—Methotrexate—colon cancer	0.00166	0.00171	CcSEcCtD
Nabilone—Abdominal pain—Capecitabine—colon cancer	0.00165	0.0017	CcSEcCtD
Nabilone—Body temperature increased—Capecitabine—colon cancer	0.00165	0.0017	CcSEcCtD
Nabilone—Convulsion—Methotrexate—colon cancer	0.00165	0.0017	CcSEcCtD
Nabilone—Chest pain—Methotrexate—colon cancer	0.00162	0.00167	CcSEcCtD
Nabilone—Arthralgia—Methotrexate—colon cancer	0.00162	0.00167	CcSEcCtD
Nabilone—Myalgia—Methotrexate—colon cancer	0.00162	0.00167	CcSEcCtD
Nabilone—Discomfort—Methotrexate—colon cancer	0.0016	0.00165	CcSEcCtD
Nabilone—Confusional state—Methotrexate—colon cancer	0.00157	0.00161	CcSEcCtD
Nabilone—Infection—Methotrexate—colon cancer	0.00155	0.00159	CcSEcCtD
Nabilone—Hypersensitivity—Capecitabine—colon cancer	0.00154	0.00158	CcSEcCtD
Nabilone—Hyperhidrosis—Methotrexate—colon cancer	0.0015	0.00155	CcSEcCtD
Nabilone—Asthenia—Capecitabine—colon cancer	0.0015	0.00154	CcSEcCtD
Nabilone—Anorexia—Methotrexate—colon cancer	0.00148	0.00153	CcSEcCtD
Nabilone—Pruritus—Capecitabine—colon cancer	0.00148	0.00152	CcSEcCtD
Nabilone—Hypotension—Methotrexate—colon cancer	0.00145	0.0015	CcSEcCtD
Nabilone—Diarrhoea—Capecitabine—colon cancer	0.00143	0.00147	CcSEcCtD
Nabilone—Musculoskeletal discomfort—Methotrexate—colon cancer	0.00142	0.00146	CcSEcCtD
Nabilone—Insomnia—Methotrexate—colon cancer	0.00141	0.00145	CcSEcCtD
Nabilone—Paraesthesia—Methotrexate—colon cancer	0.0014	0.00144	CcSEcCtD
Nabilone—Dyspnoea—Methotrexate—colon cancer	0.00139	0.00143	CcSEcCtD
Nabilone—Somnolence—Methotrexate—colon cancer	0.00138	0.00142	CcSEcCtD
Nabilone—Dizziness—Capecitabine—colon cancer	0.00138	0.00142	CcSEcCtD
Nabilone—Dyspepsia—Methotrexate—colon cancer	0.00137	0.00141	CcSEcCtD
Nabilone—Decreased appetite—Methotrexate—colon cancer	0.00135	0.00139	CcSEcCtD
Nabilone—Fatigue—Methotrexate—colon cancer	0.00134	0.00138	CcSEcCtD
Nabilone—Pain—Methotrexate—colon cancer	0.00133	0.00137	CcSEcCtD
Nabilone—Vomiting—Capecitabine—colon cancer	0.00133	0.00137	CcSEcCtD
Nabilone—Rash—Capecitabine—colon cancer	0.00132	0.00136	CcSEcCtD
Nabilone—Dermatitis—Capecitabine—colon cancer	0.00132	0.00136	CcSEcCtD
Nabilone—Headache—Capecitabine—colon cancer	0.00131	0.00135	CcSEcCtD
Nabilone—Feeling abnormal—Methotrexate—colon cancer	0.00128	0.00132	CcSEcCtD
Nabilone—Gastrointestinal pain—Methotrexate—colon cancer	0.00127	0.00131	CcSEcCtD
Nabilone—Nausea—Capecitabine—colon cancer	0.00124	0.00128	CcSEcCtD
Nabilone—Body temperature increased—Methotrexate—colon cancer	0.00123	0.00127	CcSEcCtD
Nabilone—Abdominal pain—Methotrexate—colon cancer	0.00123	0.00127	CcSEcCtD
Nabilone—Hypersensitivity—Methotrexate—colon cancer	0.00115	0.00118	CcSEcCtD
Nabilone—Asthenia—Methotrexate—colon cancer	0.00112	0.00115	CcSEcCtD
Nabilone—Pruritus—Methotrexate—colon cancer	0.0011	0.00113	CcSEcCtD
Nabilone—Diarrhoea—Methotrexate—colon cancer	0.00106	0.0011	CcSEcCtD
Nabilone—Dizziness—Methotrexate—colon cancer	0.00103	0.00106	CcSEcCtD
Nabilone—Vomiting—Methotrexate—colon cancer	0.00099	0.00102	CcSEcCtD
Nabilone—Rash—Methotrexate—colon cancer	0.000981	0.00101	CcSEcCtD
Nabilone—Dermatitis—Methotrexate—colon cancer	0.00098	0.00101	CcSEcCtD
Nabilone—Headache—Methotrexate—colon cancer	0.000975	0.001	CcSEcCtD
Nabilone—Nausea—Methotrexate—colon cancer	0.000924	0.000951	CcSEcCtD
